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GEF and the Cdc42-responsive Rac1
GEF, they showed that forskolin stimu-
lated lamellipodial formation. Impor-
tantly, removal of either GEF or replac-
ing with a nonresponsive synthetic
GEF abrogated this activity. Interest-
ingly, they show that the 2-step cas-
cade transforms theMichaelis-Menten
kinetics of their system into anonlinear,
ultrasensitiveresponse,consistentwith
predictions from theoretical studies.
In summary, this paper takes a few
steps farther on the road to synthetic
biology. The use of a novel autoinhibi-
tory interaction that is kinase respon-
sive (and can be triggered with a small
molecule) is a major accomplishment.
In so doing, Yeh et al. (2007) have suc-
cessfully reconnected some of the
core currencies of information used in
cell signaling, e.g., protein phosphory-
lation and GTPases. These are ele-
ments that can in principle be used
both as node inputs and outputs, and
which therefore are used extensively
in complex circuits in nature. It remains
to be seen whether this strategy can
be generalized to other kinases or pair-
wise binding partners. The attempt
to transfer the specific domains to
numerous GEFs is laudable, and the
better than 50% rate of success is re-
markable given the number of possible
modes of failure for protein re-engi-
neering, and suggests the authors’
implication that module swapping in
proteins may in fact be more robust
than previously thought. Whether
this strategy can be truly transferred
to all Dbl-containing GEFs cannot be
assessed until it is clear how the
three nonresponsive synthetic GEFs
failed.
While these efforts are encouraging,
we are still a long way from the level of
control in Rho GTPase signaling ex-
hibited by cells. Cells in vivo rarely
produce only filopodia or lamellipodia.
Instead, these structures form and
disappear on the order of seconds to
minutes, and do so with spatially
organized patterns across the cell, of-
ten with different classes of actin mi-
croarchitecture coexisting in different
parts of the cell. Thus, understanding
how to activate or inactivate certain
pathways is only a first step. Knowing
how to engineer these signals in space
and time, to control their localization
and transport, and how to operate
multiple pathways simultaneously, re-
main a mystery. As such, we are cur-
rently more tinkerer than designer.
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Recent findings in mouse and zebrafish embryos, as well as in embryonic stem cells, emphasize the
critical importance of the Wnt/b-catenin pathway in the regulation of cardiogenesis, and highlight the
exquisite timing and specific cellular responses by which this signaling pathway exerts its influence.
These studies clearly demonstrate that the Wnt/b-catenin pathway plays distinct, even opposing,
roles during various stages of cardiac development.The diversity of cardiac progenitor
populations in various vertebrate spe-
cies is an emerging area of intense fo-
cus in many laboratories; knowledge
of these progenitors has profound
implications for our understanding of
heart development during embryogen-
esis, and also highlights the enormous
therapeutic potential of these avenues10 Developmental Cell 13, July 2007 ª20for regenerative medicine. In the verte-
brate embryo, cardiac progenitors de-
rive from the lateral plate mesoderm,
migrate to form the cardiac crescent,
and subsequently contribute to the
myocardium and endocardium of the
heart. Recent studies indicate that
the heart is formed from two distinct
mesoderm populations or ‘‘heart07 Elsevier Inc.fields’’ that arise from a common origin
and express both distinct and overlap-
ping molecular markers. The earliest
population of cardiac progenitors, the
first heart field, corresponds to the
anterior lateral mesoderm and sub-
sequently to the cardiac crescent. Ulti-
mately, cells from the first heart field
contribute to the left ventricle and
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precursors, the second heart field,
derives from mesoderm cells located
medial to the cardiac crescent. These
cells contribute primarily to the car-
diac outflow tract (OFT), right ventricle
(RV) and atria (Buckingham et al.,
2005).
The influence of various signaling
molecules on cardiogenesis is gradu-
ally being clarified. BMPs and FGFs
were found to positively regulate car-
diac specification and differentiation.
In contrast, in both chick and frog em-
bryos, members of the canonical Wnt
signaling pathway, acting via its major
transducer, b-catenin, were shown to
repress early cardiac specification by
maintaining the correct boundaries
and size of the pre-cardiac mesoderm
(Marvin et al., 2001; Schneider and
Mercola, 2001; Tzahor and Lassar,
2001) (Figure 1A). Despite subsequent
findings supporting the notion that inhi-
bition of the Wnt/b-catenin pathway is
required for heart development, other
results, mostly in cultured embryonic
stem (ES) cells, suggest that the oppo-
site is true (reviewed in Eisenberg and
Eisenberg, 2006). The seemingly con-
tradictory effects of the Wnt/b-catenin
pathway during cardiogenesis could
be resolved, assuming that this path-
way performs different functions at
various developmental stages by acti-
vating distinct downstream effectors.
A recent wave of studies in zebrafish
and mouse embryos, as well as in ES
cells, details the exquisite timing nec-
essary to properly orchestrate cardiac
development, and sheds new light on
the regulation of cardiogenesis by
the Wnt/b-catenin pathway (Ai et al.,
2007; Cohen et al., 2007; Kwon
et al., 2007; Lin et al., 2007; Qyang
et al., 2007; Ueno et al., 2007). Manip-
ulation of Wnt/b-catenin signaling in
developing zebrafish embryos demon-
strated how this pathway promotes
cardiac differentiation prior to gastru-
lation, and inhibits heart formation dur-
ing gastrulation (Ueno et al., 2007).
Strikingly, the response of heart pre-
cursors to Wnt/b-catenin signaling
switched from positive to negative
during an hour-long developmental
window, which occurs at the begin-
ning of gastrulation (Figure 1B). Ueno
et al. (2007) conclude that during earlyFigure 1. The Multiple Roles Played by the Wnt/b-Catenin Pathway in the Regulation
of Cardiogenesis
(A) Wnt/b-catenin signaling represses cardiac cell fate specification (red staining) at discrete
stages of chick embryogenesis. Wnt signals in the primitive streak prevent cardiogenesis in the
posterior lateral plate mesoderm (on the left [Marvin et al., 2001]). Likewise, a putative Wnt signal
emanating from the neural tube blocks cardiogenesis in the cranial paraxial mesoderm (on the right
[Tzahor and Lassar, 2001]). The dashed line demarcates the border between the cranial paraxial
mesoderm and the cardiac mesoderm, including the two heart fields (red cells). A-P, anterior-
posterior; M-L, medial-lateral; D-V, dorsal-ventral.
(B) In zebrafish embryos, Wnt/b-catenin signaling promotes cardiogenesis prior to gastrulation
and inhibits heart specification at a later developmental stage, as assayed using heat-shocked
(hs) Wnt8 and Dkk1 transgenic zebrafish embryos (Ueno et al., 2007).
(C) A panel of cardiac-specificmouseCre lines (Isl1-Cre [Kwon et al., 2007; Lin et al., 2007], Mef2c-
AHF-Cre [Ai et al., 2007; Qyang et al., 2007], Nkx2.5-Cre [Kwon et al., 2007], SM22-Cre [Cohen
et al., 2007]) was used to show that the Wnt/b-catenin pathway regulates second heart field de-
rivatives such as the right ventricle (RV) and cardiac outflow tract (OFT), as well as the branchial
arches (BA).
(D) Based on the findings of Qyang et al. (2007), a proposed model for temporally distinct roles of
Wnt/b-catenin signals during pre-specification, renewal, and differentiation of a set of Isl1+ cardio-
vascular progenitors is shown. The model depicts how Wnt/b-catenin signals secreted from car-
diac mesenchymal cells act in a sequential fashion, first by blocking the pre-specification of Isl1+
cardiovascular progenitors, later by promoting their renewal, and subsequently by blocking their
terminal differentiation into cardiomyocytes and smooth muscle. In addition, Ueno et al. (2007)
showed that the Wnt/b-catenin pathway initially promotes mesoderm formation, and also induces
a negative feedback loop, which could in turn enhance cardiac cell fate.Developmental Cell 13, July 2007 ª2007 Elsevier Inc. 11
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Previewsembryonic development, the Wnt/
b-catenin pathway induces the forma-
tion of the lateral mesoderm, whereas
its negative role/repressive activity
helps to define the proper size of the
heart-forming field, in agreement with
previous studies (Figure 1A).
In the mouse, genetic loss- and
gain-of-function alleles of b-catenin
were crossed with a panel of Cre lines
to perturb Wnt/b-catenin signaling in
the heart. Ablation of b-catenin re-
sulted in lethality, which was attributed
to defects in second heart field deriva-
tives: the right ventricular chamber,
outflow tract, and pharyngeal meso-
derm (Figure 1C). Importantly, disrup-
tions in Wnt/b-catenin signaling can
trigger the onset of OFT defects, a ma-
jor form of human congenital heart dis-
ease. These studies further indicate
that Wnt/b-catenin signaling is a nec-
essary prerequisite for normal prolifer-
ation of second heart field cells. Con-
versely, genetic activation of the Wnt/
b-catenin pathway using a stabilized
form of b-catenin resulted in marked
proliferation of second heart field pro-
genitors that accumulated in the OFT
and RV (Ai et al., 2007; Cohen et al.,
2007; Kwon et al., 2007; Qyang et al.,
2007). Among the potential down-
stream targets analyzed in these stud-
ies, it has been shown that b-catenin
directly targets and activates Isl1 (Lin
et al., 2007) and Fgf10 (Cohen et al.,
2007) expression. These findings sug-
gest a link between Wnt and FGF sig-
naling pathways in the expansion of
Isl1+ progenitors in the second heart
field.
It has been suggested that human
ES cells could serve as a renewable
source for cardiac muscle regenera-
tion. Accordingly, some groups (Kwon
et al., 2007; Qyang et al., 2007; Ueno
et al., 2007) combined the aforemen-
tioned developmental insights with a
clinical orientation, in order to study
cardiogenesis in cultured mouse ES
cells. ES cells form clusters called em-
bryoid bodies (EBs) that differentiate,
in a seemingly random fashion, into de-
rivatives of the three germ layers; they
can even formbeating cardiomyocytes,
although with low frequency. Addition
of Wnt-3A ligand to early EB cultures
dramatically accelerated the onset of
beating activity and increased expres-12 Developmental Cell 13, July 2007 ª20sion of cardiac genes (Kwon et al.,
2007; Ueno et al., 2007). Disrupting ca-
nonical Wnt signaling activity with
Dkk-1, a known inhibitor of this path-
way, resulted in the complete absence
of beating EBs, suggesting that canon-
ical Wnt signaling during a specific de-
velopmental window not only promotes
cardiomyocyte formation in ES cells,
but is a necessary prerequisite for its
occurrence (Kwon et al., 2007).
Supporting their findings in zebra-
fish embryos, (Ueno et al., 2007) also
used the ES/EB culture assay to
demonstrate that the Wnt/b-catenin
pathway plays a biphasic role (both
positive and negative) in controlling
differentiation of cardiomyocytes, in
agreement with an earlier report (Naito
et al., 2006). A plausible mechanistic
explanation for the biphasic nature of
Wnt/b-catenin signaling lies in the
finding that Wnt-3A application to ES
cells activates a feedback loop that
can repress the Wnt pathway, thereby
promoting cardiac cell differentiation
(Ueno et al., 2007) (Figure 1D). The ac-
tivation of a negative feedback loop
appears to be a common theme in
many signaling networks, as demon-
strated recently within the context of
BMP signaling during embryonic heart
development (Prall et al., 2007).
Qyang et al. (2007) depicted the
complexity of Wnt/b-catenin signaling
in cardiogenesis by ‘‘zooming in’’ at
high resolution on discrete develop-
mental steps such as pre-specification,
renewal, and differentiation, using a
panel of purified Isl1+ cardiovascular
progenitors (embryo-derived, ES cell-
derived, neonatal-derived) previously
described by this group. In this system,
canonical Wnt signals secreted from
cardiac mesenchymal feeder cells,
which mimic the in vivo microenviron-
ment, first trigger the renewal and ex-
pansion of Isl1+ cells, but also inhibit
their differentiation. Thus, this pathway
can play a critical inhibitory role in the
initial formation (and subsequent dif-
ferentiation) of Isl1 cardiovascular pro-
genitors (presumably titrating their
number), later acting as a positive sig-
nal for committed Isl1 progenitors
(Qyang et al., 2007) (Figure 1D). Taken
together, these new findings under-
score the complex nature of Wnt/
b-catenin signaling in cardiogenesis,07 Elsevier Inc.and suggest that manipulation of this
pathway may promote the derivation
of various cardiac cell types for thera-
peutic applications.
The process of stem cell renewal,
expansion, and differentiation is far
more likely to occur in the embryo
than in the adult. As shown in the afore-
mentioned studies, the insights of
developmental biologists can help to
clarify the molecular mechanisms that
govern stem cell behavior, and thus
potentially assist in the development
of cell-based therapies for regenera-
tive medicine. These high-resolution
in vivo and in vitro analyses demon-
strate that the Wnt/b-catenin pathway
plays distinct and even opposing roles
at various stages of cardiac develop-
ment. These discoveries highlight the
challenges inherent in directing the
differentiation of pluripotent ES cells,
since manipulation of these processes
involves not only a thorough under-
standing of the interacting signaling
pathways, but also the ability to accu-
rately control the temporal order in
which theyare used. In the future, stud-
ies addressing signaling mechanisms
during embryogenesis should take
into consideration their temporal and
dynamic nature, as well as their cross-
talk with other signaling networks.
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